Skip to main content
Dr Panagiotis Koliou Accepting new patients

Dr.

Dr Panagiotis Koliou

Oncology

Verified by EuroClinics European Board of Oncology Trust score 98/100

5 17 verified reviews

Speaks
  • 🇬🇧
  • 🌍
English · Greek
4,816+ Patients seen
1 Years practising
16 h-index
5 / 5 Patient rating
Watch 119s introduction
From 180.00 EUR first consult
Next slot 2026-05-29 16:00
Credentials verified License + board cert checked
5 · 17 reviews 100% verified visits
GDPR · EU residency Field-level encrypted
Free cancellation 24h before slot
Specialises in
  • GP consultation
  • Annual physical exam
  • Vaccination administration
  • Minor procedure (skin)
Treats

About Dr Panagiotis Koliou

Dr Panagiotis Koliou is a highly experienced Consultant Medical Oncologist with over 17 years of clinical practice, specialising in the management of early and advanced breast cancer. He is recognised for delivering personalised, evidence-based care, combining the latest advances in oncology with a compassionate, patient-centred approach. His expertise spans the full range of systemic anticancer treatments, including endocrine therapy, chemotherapy, antibody–drug conjugates, targeted therapies and immunotherapy. Dr Koliou treats patients across both standard care pathways and cutting-edge clinical trials, ensuring access to the most innovative therapies available. Dr Koliou graduated in Medicine from the University of Ioannina and holds an honours degree in Biochemistry from Benedictine University, USA. He completed a Master’s degree in Clinical Biochemistry and Molecular Biology at the University of Surrey and was awarded a PhD in Medical Oncology with First Class honours from University of Ioannina, Greece. He undertook specialist training in Medical Oncology at the Aristotle University of Thessaloniki in Greece and at University College London Hospital. He has a strong interest in precision oncology, using advanced molecular and genomic profiling to tailor treatments to each individual patient. His work incorporates the use of circulating tumour DNA and other liquid biopsy technologies to guide treatment decisions and monitor disease in real time. Dr Koliou has extensive experience in managing complex metastatic breast cancer, with particular expertise in sequencing therapies and optimising outcomes across multiple lines of treatment. He is also an active contributor to research and innovation, having served as Principal Investigator in multiple Phase III clinical trials in breast cancer and melanoma at Royal Surrey, helping to bring forward new standards of care. Known for his clarity, attention to detail and commitment to excellence, Dr Koliou works closely with multidisciplinary teams to ensure each patient receives the highest standard of care throughout their treatment journey.

"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."

— Dr Panagiotis Koliou, on practice philosophy

Credentials & verification

active

Medical license

Organización Médica Colegial de España (OMC) · GB

#GB-395562

Valid until 2028-12-31

Verify with issuer
Certified

Board certification

European Board of Oncology

#EB-F86C2D70

Renewal due 2038

Verify with issuer
In good standing

Malpractice cover

Generali Healthcare

5,000,000 EUR

Valid until 2026-12-31

No claims on file

Education & training

  1. 2017–2023
    MD · Medicine and Surgery

    Universidad de Navarra (GB)

  2. 2023–2027
    Residency · Oncology

    Universitat de Barcelona (GB)

Career & appointments

  1. 2027-09–2028-08
    Junior consultant

    Universidad de Navarra Teaching Hospital — Oncology

Procedures & conditions

Procedure Code Lifetime volume
GP consultation 99213 1,257
Annual physical exam 99395 2,071
Vaccination administration 90471 207
Minor procedure (skin) 17110 1,152

Patient reviews

See all 17
5
★★★★★
17 verified reviews
100% verified visits
bedside manner 5
knowledge 5
wait time 4.75
staff friendliness 5
ease of appointment 4.9
value for money 4.92
would recommend pct 99
★★★★★

"Very thorough first visit — explained every step. Booking was easy and the staff were welcoming."

Anna B. · 2026-05-01 Verified
★★★★★

"Took time to listen and reviewed all my previous results. I would absolutely recommend."

Marco V. · 2026-04-20 Verified
★★★★

"Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent."

Helena F. · 2026-04-15 Verified
Patients seen 4,687
Avg rating 5 / 5
Typical wait 12 days
Research h-index 16

Recognition & press

Awards

  • Top-rated Oncology — — EuroClinics Patient Choice · 2025 regional
  • Excellence in Patient Care — National Society · 2024 national
  • Young Investigator Award — European Society · 2023 international

Society memberships

  • WONCA Europe — Family Doctors — Member · since 2028
  • national college of family doctors — Member · since 2028
  • European Union of Medical Specialists (UEMS) — Member · since 2028

Your consultation, step by step

  1. 1 Choose a slot
  2. 2 Brief pre-consult form
  3. 3 Consultation
  4. 4 Follow-up note & plan

Average end-to-end time: 45 minutes · Free cancellation up to 24h before · Telemed or in-clinic — your choice

Services & pricing

New patient consultation (60m)

60 min in_clinic|telemed

Follow-up consultation (30m)

30 min in_clinic|telemed|phone

Vaccination administration

90 min in_clinic

Minor procedure (skin)

60 min in_clinic

Insurance compatibility

In-network Direct billing
In-network Direct billing
In-network Direct billing
In-network Direct billing
Not sure if your insurer is covered? Verify your plan in 30 seconds — no signup required.
Verify my insurance

For international patients

Multilingual care

Coordinator: Patient liaison · panagiotis.koliou@euroclinics.example. Care delivered in English · Greek.

Travel & transfer

Aftercare worldwide

Coordinated follow-up by request.

Research & publications

h-index: 16 · i10: 7

Selected publications

  1. Validation of clinical scoring in Oncology

    Dr Panagiotis Koliou, et al. · European Journal of Medicine, 2026

  2. Long-term follow-up of Oncology across GB

    Dr Panagiotis Koliou, et al. · European Journal of Medicine, 2025

  3. Validation of clinical scoring in Oncology

    Dr Panagiotis Koliou, et al. · European Journal of Medicine, 2024

Show full research record

Invited talks

  • Practical updates in Oncology · European Annual Congress (Oncology) · Vienna · 2024
  • Single-centre experience in Oncology · National Society Meeting · · 2023

Articles by Dr Panagiotis Koliou

Frequently asked

01. Do you accept new patients?

Dr Panagiotis Koliou is currently accepting new patients. Use the booking module to choose a slot.

02. Which languages can I be seen in?

Consultations are available in English, Greek.

03. Is the consultation in-person or online?

Most services are offered both in-clinic and via telemedicine. Each service card above marks its modalities.

04. Do you accept my insurance?

In-network with major international insurers (Allianz Worldwide, AXA Global, BUPA Global and others). Use the "Verify my insurance" button to confirm your plan.

05. What is the cancellation policy?

Free cancellation up to 24 hours before your slot. Last-minute cancellations may incur a small administrative fee.

06. How is my health data protected?

All records are stored on EU servers, field-level encrypted, and GDPR compliant. Data is never shared with third parties without your explicit consent.

Ready to book

Book Dr Panagiotis Koliou

★ 5 · 17 reviews From 180.00 EUR first consult Free cancellation 24h before
Message Book a slot